Rohit Kadam turns molecular research into scalable diagnostics that serve frontline clinics, not just publications.

HOLX's Molecular Diagnostics growth stays resilient, as new assays and test adoption offset funding headwinds.

Government initiatives promoting healthcare infrastructure development and growing investments in research further support ...

Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.

QuidelOrtho’s first quarter results received a strong positive reaction from the market, driven by better-than-expected ...

Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, announced today the launch of STAgora™, a ...

The global Esoteric Testing Market is valued at USD 30.56 billion in 2024 and is projected to reach a value of USD 84.12 ...

At APL, a team is developing portable tech to detect ocean species using eDNA. Their goal: real-time, low-cost monitoring to ...

A contagious new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States, CDC data show. What to know about symptoms and vaccines.

When the first reports of a new COVID-19 variant emerge, scientists worldwide scramble to answer a critical question: Will ...

A study published in mBio details the vulnerability of coronaviruses to inhibitors of a small protein domain called Mac1, or the "macrodomain," found in all coronaviruses such as SARS-CoV-2 and ...

In this interview, Professor James J. Collins, founder of the field of Synthetic Biology, discusses his journey to founding ...